Technical Analysis for RSLS - Reshape Lifesciences Inc

Grade Last Price % Change Price Change
grade B 0.1 0.00% 0.0000
RSLS closed unchanged on Monday, July 15, 2019, on 12 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical RSLS trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Calm After Storm Range Contraction 0.00%

Older signals for RSLS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ReShape Lifesciences Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; and ReShape Balloon system that uses balloon technology designed to take up room in the stomach to enable people lose weight. Its product portfolio also comprises ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.
Medicine Medical Specialties Clinical Medicine Obesity Metabolic Diseases Gastrointestinal Disorders Digestive System Surgery Vagus Nerve Laparoscopy
Is RSLS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.4
52 Week Low 0.041
Average Volume 124,513
200-Day Moving Average 0.0
50-Day Moving Average 0.0777
20-Day Moving Average 0.0684
10-Day Moving Average 0.0807
Average True Range 0.0126
ADX 31.2
+DI 34.1686
-DI 11.959
Chandelier Exit (Long, 3 ATRs ) 0.0822
Chandelier Exit (Short, 3 ATRs ) 0.0788
Upper Bollinger Band 0.108
Lower Bollinger Band 0.0288
Percent B (%b) 0.9
BandWidth 115.789474
MACD Line 0.0057
MACD Signal Line -0.0012
MACD Histogram 0.0069
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1000
Resistance 3 (R3) 0.1000 0.1000 0.1000
Resistance 2 (R2) 0.1000 0.1000 0.1000 0.1000
Resistance 1 (R1) 0.1000 0.1000 0.1000 0.1000 0.1000
Pivot Point 0.1000 0.1000 0.1000 0.1000 0.1000
Support 1 (S1) 0.1000 0.1000 0.1000 0.1000 0.1000
Support 2 (S2) 0.1000 0.1000 0.1000 0.1000
Support 3 (S3) 0.1000 0.1000 0.1000
Support 4 (S4) 0.1000